Expression of CD25 antigen on CD34+ cells is an independent predictor of outcome in late-stage MDS patients treated with azacitidine.
Miltiades P, Lamprianidou E, Vassilakopoulos TP, Papageorgiou SG, Galanopoulos AG, Vakalopoulou S, Garypidou V, Papaioannou M, Hadjiharissi E, Pappa V, Papadaki HA, Spanoudakis E, Tsatalas K, Kotsianidis I.
Miltiades P, et al. Among authors: spanoudakis e.
Blood Cancer J. 2014 Feb 28;4(2):e187. doi: 10.1038/bcj.2014.9.
Blood Cancer J. 2014.
PMID: 24583533
Free PMC article.
No abstract available.